<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Liver is one of the commonest sites of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>Solitary <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> or oligometastasis are traditionally treated by surgical resection or chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>DISCUSSION: There may be a subgroup of these patients who are not suitable for surgery or chemotherapy due to various co-morbid factors </plain></SENT>
<SENT sid="3" pm="."><plain>These patients can be treated by novel minimally invasive or noninvasive ablative techniques like interstitial brachytherapy, extracranial stereotactic radiotherapy, and radiofrequency ablation </plain></SENT>
</text></document>